Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
CC transcript
Quarterly results
Appointed director
|
|
Viracta Therapeutics, Inc. (VIRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
3
| Cohen Darrel P. (Chief Medical Officer) has filed a Form 3 on Viracta Therapeutics, Inc. |
| 09/19/2022 |
3
| Rothera Mark (President and CEO) has filed a Form 3 on Viracta Therapeutics, Inc. |
| 08/11/2022 |
3
| Chung Jane (Director) has filed a Form 3 on Viracta Therapeutics, Inc. |
| 08/17/2021 |
3
| Borellini Flavia (Director) has filed a Form 3 on Viracta Therapeutics, Inc. |
| 08/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/04/2021 |
3
| Rubino Stephen (Director) has filed a Form 3 on Viracta Therapeutics, Inc. |
| 02/25/2021 |
3
| aMoon 2 Fund Limited Partnership (10% Owner) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 02/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/24/2021 |
3
| DARCY THOMAS E (Director) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 02/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/24/2021 |
3
| Pomerantz Roger (Director) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 02/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/24/2021 |
3
| ROYSTON IVOR (CEO & President) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 01/07/2021 |
3
| Hyare Parvinder S (See Remarks) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 05/05/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/27/2019 |
3
| ONETTO NICOLE (Director) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 03/25/2019 |
3
| Fox Judith A. (Chief Scientific Officer) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 01/24/2019 |
3
| Aisling Capital IV, LP (10% Owner) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 07/03/2018 |
3
| Wolff Henry Ward (Director) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 12/04/2017 |
3
| Quinn William P. (CFO,Sr.V.P. Finance, Corp.Dev.) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 10/31/2017 |
3
| MPM Oncology Impact Management GP LLC (10% Owner) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 04/01/2016 |
3
| Parker Geoffrey M. (Director) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 06/24/2013 |
3
| Carchedi Steve (Director) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 03/02/2012 |
3
| Craig Adam R (EVP, Development & CMO) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 03/12/2010 |
3
| Semon Dominique (10% Owner) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 07/28/2009 |
3
| Kim Helen Susan (Director) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 04/07/2009 |
3
| Misfeldt Dayton (10% Owner) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 04/07/2009 |
3
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 04/07/2009 |
3
| HURWITZ EDWARD (10% Owner) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 04/07/2009 |
3
| ALTA BIOPHARMA PARTNERS III LP (10% Owner) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 04/06/2009 |
3
| Growth Equity Opportunities Fund, LLC (10% Owner) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
|
|
|